Back
ProShares Short 20+ Yr Treasury Vs. Ascendis Pharma AS Industry Stock Comparison
Sell
39
TBF
ProShares Short 20+ Yr Treasury
Last Price:
$24.83
Seasonality Move:
-4.12%
Sell
41
ASND
Ascendis Pharma AS
Last Price:
$170.78
Seasonality Move:
11.21%
Sell
39
ProShares Short 20+ Yr Treasury (TBF)
is a Sell
Is ProShares Short 20+ Yr Treasury a Buy, Sell or Hold?
-
The current ProShares Short 20+ Yr Treasury [TBF] share price is $24.81. The Score for TBF is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
TBF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Ascendis Pharma AS (ASND)
is a Sell
Is Ascendis Pharma AS a Buy, Sell or Hold?
-
The current Ascendis Pharma AS [ASND] share price is $170.80. The Score for ASND is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
ASND is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
TBF Stock Price Chart
What is ProShares Short 20+ Yr Treasury's stock price today?
-
The ProShares Short 20+ Yr Treasury share price today is $24.81The current trend is relatively stagnant and TBF is experiencing slight selling pressure.
ASND Stock Price Chart
What is Ascendis Pharma AS's stock price today?
-
The Ascendis Pharma AS share price today is $170.80The current trend is moderately bullish and ASND is experiencing slight selling pressure.
TBF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.04 | Buy |
| Relative Strength Index (14 RSI): | 49.41 | Sell |
| Chaikin Money Flow: | -8579 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (24.74 - 25.2) | Sell |
| Bollinger Bands (100): | (23.81 - 24.87) | Buy |
ASND Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.42 | Buy |
| Relative Strength Index (14 RSI): | 56.29 | Buy |
| Chaikin Money Flow: | -165847 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (157.14 - 172.28) | Buy |
| Bollinger Bands (100): | (137.79 - 167.93) | Buy |
TBF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.85 | Sell |
| 20-day SMA: | 25.01 | Sell |
| 50-day SMA: | 24.61 | Buy |
| 200-day SMA: | 23.83 | Buy |
| 8-day EMA: | 24.86 | Sell |
| 20-day EMA: | 24.88 | Sell |
| 50-day EMA: | 24.67 | Buy |
| 200-day EMA: | 24.09 | Buy |
ASND Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 172.91 | Sell |
| 20-day SMA: | 166.8 | Buy |
| 50-day SMA: | 161.03 | Buy |
| 200-day SMA: | 142.93 | Buy |
| 8-day EMA: | 171.3 | Sell |
| 20-day EMA: | 168.21 | Buy |
| 50-day EMA: | 162.52 | Buy |
| 200-day EMA: | 147.14 | Buy |
ProShares Short 20+ Yr Treasury Earnings Growth & TBF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Ascendis Pharma AS Earnings Growth & ASND Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.60 per share, an increase next quarter of $0.47 per share, an increase this year of $2.37 per share, and an increase next year of $7.10 per share.
ProShares Short 20+ Yr Treasury Technical Analysis
| Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ascendis Pharma AS Technical Analysis
| Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||